Seeking Alpha

While Illumina (ILMN +3.9%) has rebounded from the weakness caused by Life Technologies' (LIFE...

While Illumina (ILMN +3.9%) has rebounded from the weakness caused by Life Technologies' (LIFE +7.2%) product announcement, smaller rival Complete Genomics' (GNOM -19.9%) bloodletting worsens as the day progresses. On Monday, the company announced it delivered 300 fewer genomes in Q4 than previously expected, news that triggered a downgrade from Oppenheimer.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)